PET (positron emission tomography) beats SPECT (single photon emission computed tomography) as heart risk diagnostic
This article was originally published in Clinica
Executive Summary
Positron emission tomography (PET) scanning is more accurate, less invasive and more cost effective than single photon emission computed tomography (SPECT) imaging when used as the first tool to diagnose cardiac vessel blockages. So suggest the results of a trial conducted at the State University of New York, published in the July edition of the Journal of Nuclear Medicine. Lead researcher Dr Michael Merhige, clinical associate professor of nuclear medicine at the university, said that the researchers found a more than 50% decrease in the use of invasive coronary arteriography and coronary artery bypass grafting when PET was used as the first-line test.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.